+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

JEMPERLI (dostarlimab) Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

JEMPERLI (dostarlimab) Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Waldenstrom's Macroglobulinaemia - Pipeline Insight, 2022 - Product Thumbnail Image

Waldenstrom's Macroglobulinaemia - Pipeline Insight, 2022

  • Clinical Trials
  • November 2022
  • 80 Pages
  • Global
From
Cholangiocarcinoma (CCA) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Cholangiocarcinoma (CCA) - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 162 Pages
  • Global
From
From
Intratumoral Cancer Therapies - Epidemiology Forecast - 2032 - Product Thumbnail Image

Intratumoral Cancer Therapies - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 144 Pages
  • Global
From
From
Pancreatic Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

Pancreatic Cancer - Epidemiology Forecast - 2032

  • Report
  • August 2022
  • 142 Pages
  • Global
From
From
Rare NRG1 Fusion - Epidemiology Forecast - 2032 - Product Thumbnail Image

Rare NRG1 Fusion - Epidemiology Forecast - 2032

  • Report
  • August 2022
  • 75 Pages
  • Global
From
From
From
Waldenstrom Macroglobulinemia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Waldenstrom Macroglobulinemia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
From
From
Endometrial Cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Endometrial Cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Ewing Sarcoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Ewing Sarcoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Gastric Cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Gastric Cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more